T. Alex Perkins

Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms

Guido España, Cosmina Hogea, Adrienne Guignard et al. · PLoS ONE · 2019 · 734 citations · Full text

Vaccination, Dengue Vaccine Candidates, Infectious Disease Modelling +14

Aggregated mobility data could help fight COVID-19

Caroline O. Buckee, Satchit Balsari, Jennifer Chan et al. · Science · 2020 · 455 citations · Full text

Wastewater-Based Epidemiology: Global Collaborative to Maximize Contributions in the Fight Against COVID-19

Aaron Bivins, Devin North, Ahmad Arslan et al. · Environmental Science & Technology · 2020 · 455 citations · Full text

Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States

Estee Y. Cramer, Evan L Ray, Velma K. Lopez et al. · Proceedings of the National Academy of Sciences · 2022 · 296 citations · Full text

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

Stefan Flasche, Mark Jit, Isabel Rodríguez-Barraquer et al. · PLoS Medicine · 2016 · 230 citations · Full text